BioHarvest Sciences Net Income 2020-2024 | BHST

BioHarvest Sciences net income from 2020 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
BioHarvest Sciences Annual Net Income
(Millions of US $)
2023 $-13
2022 $-11
2021 $-10
2020 $-7
2019 $-5
2019 $-5
2018 $-5
BioHarvest Sciences Quarterly Net Income
(Millions of US $)
2024-06-30 $-1
2024-03-31 $-7
2023-12-31 $-7
2023-09-30 $-2
2023-06-30 $-3
2023-03-31 $-1
2022-12-31 $-3
2022-09-30 $-4
2022-06-30 $-2
2022-03-31 $-2
2021-12-31 $-2
2021-09-30 $-3
2021-06-30 $2
2021-03-31 $-7
2020-12-31 $-3
2020-09-30 $-2
2020-06-30 $-1
2020-03-31 $-0
2019-12-31
2019-09-30 $-1
2019-06-30 $-1
2019-03-31
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.098B $0.013B
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
Stock Name Country Market Cap PE Ratio
Primo Water (PRMB) United States $4.535B 35.81
P.A.M Transportation Services (PAMT) United States $0.430B 0.00
Rigetti Computing (RGTI) United States $0.325B 0.00
Alpha Cognition (ACOG) Canada $0.035B 0.00
Atlantic Coastal Acquisition II (ABP) United States $0.000B 0.00